Get startedLog in
    Picture of Spectrum Pharmaceuticals logo

    SPPI — Spectrum Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall Cap
    All News

    Brief: Spectrum Pharmaceuticals To Present Data At 2022 Asco Highlighting The Potential Predictive Capabilities Of Ctdna As A Biomarker For Poziotinib Treatment Response

    Picture of Spectrum Pharmaceuticals logoSpectrum Pharmaceuticals
    27/05/2022 24:50
    May 26 (Reuters) - Spectrum Pharmaceuticals Inc  SPPI.O :
    * SPECTRUM PHARMACEUTICALS TO PRESENT DATA AT 2022 ASCO
HIGHLIGHTING THE POTENTIAL PREDICTIVE CAPABILITIES OF CTDNA AS A
BIOMARKER FOR POZIOTINIB TREATMENT RESPONSE

Source text for Eikon:  ID:nBw9G2B9za 
Further company coverage:  SPPI.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Spectrum Pharmaceuticals

    See all news